IVVD תחזית צמיחת רווח נקי למניה לשנה הבאה Invivyd Inc

Invivyd, Inc. (IVVD) develops antibodies against viruses using a platform designed to protect immunocompromised individuals. This daily price chart of the consensus EPS n+1 forecast on GURU.Markets features the 37.50 level, capturing the latest values. The business model relies on external manufacturing outsourcing; however, the pricing power of the drugs is limited by a dependence on government grants and the rapid mutation of strains.

This metric measures the sensitivity of future cash flows via the consensus growth forecast for net income for the coming year. It allows for an assessment of an asset's investment safety by identifying hidden degradation of the business model before a crisis occurs. For Invivyd, Inc. (IVVD), this indicator reflects the efficiency of utilizing a CDMO production model for antibodies without capital expenditures. By analyzing the history of consensus estimates for next year's profit dynamics, an investor can timely detect the risks of inflated expectations.